جست‌وجوی استاد و پژوهشگر

• Genome Editing
• Epigenetics
• Hematopoietic Stem Cell Research
• +۴ مورد دیگر

Kendell Clement is a leading researcher in biomedical informatics and genome editing, with expertise in CRISPR technology, epigenetics, and hematopoietic stem cell research. Current affiliations include collaborative work in cancer genomics and computational biology. Education: PhD, Harvard-MIT Program in Health Sciences and Technology BS, Brigham Young University Research focuses on optimizing CRISPR-based gene editing to evade genotoxicity, developing tools like CRISPResso2 and CRISPR-SURF, and exploring epigenetic mechanisms in cancers such as multiple myeloma and chronic lymphocytic leukemia. Recent work includes in vivo modeling, single-cell analysis, and novel base editing platforms for immune cell engineering. Key trends in publications (2010–2025) span genome editing specificity, epigenetic regulation in stem cells, and cancer evolutionary dynamics. Notable contributions include patents on cancer diagnostics and therapies, as well as methods for DNA methylation profiling. Collaborative Networks: Massachusetts General Hospital (Postdoctoral Fellowship) Harvard-MIT Program (Doctoral Training) Free University (Fellowship)

J. Dafhne Aguirreمشاهده پروفایل

دانشیار

• Biochemistry
• Molecular Biology
• Chemical Biology
• +۳ مورد دیگر

J. Dafhne Aguirre is an Associate Professor in Residence at the University of Connecticut , affiliated with the Department of Chemistry . Her academic journey includes a Postdoctoral Fellowship at Johns Hopkins University , a Ph.D. from Texas A&M University , and a B.Sc. from Pontificia Universidad Catolica del Peru . Education: Postdoctoral Fellow, Johns Hopkins University Ph.D., Texas A&M University B.Sc., Pontificia Universidad Catolica del Peru Dr. Aguirre’s research spans Biochemistry , Molecular Biology , and Chemical Biology , with a focus on ubiquitination mechanisms , DNA repair pathways , and metal-based anticancer compounds . Her work explores the structural and functional dynamics of proteins like parkin and UBR5, as well as the photophysical properties of dirhodium complexes. Recent publications highlight advancements in ubiquitin signaling , mitochondrial quality control , and metallodrug design . Her studies on dirhodium complexes for DNA photocleavage and anticancer activity demonstrate applications in Medicinal Chemistry and Photochemistry . Contact: jdaguirre@uconn.edu | Phone: (860) 486-3217

Christopher Schatschneiderمشاهده پروفایل

استاد

• Educational Psychology
• Learning Disabilities
• Quantitative Methods
• +۳ مورد دیگر

Christopher Schatschneider is a Professor of Psychology at Florida State University (FSU) and serves as Associate Director of the Quantitative Methodology and Innovative Division at the Florida Center for Reading Research (FCRR). His research focuses on educational psychology, learning disabilities, and quantitative methods, with particular emphasis on reading and language comprehension. He leads initiatives in research design, statistical methodology, and measurement, contributing to evidence-based interventions in education. Dr. Schatschneider’s work emphasizes data-driven approaches, including universal screening methods, educational data sharing, and the application of advanced statistical techniques. He collaborates on projects addressing disparities in reading disability identification, early childhood interventions for autism spectrum disorder, and optimizing teacher practices through data-based individualization. His research spans K-12 and postsecondary education, with a commitment to translational science and community impact. Recent publications highlight his expertise in educational measurement, morphological instruction, and the intersection of genetics and learning. He co-developed the LDbase data repository to foster collaborative research in learning disabilities. His work often bridges quantitative rigor with practical educational applications, such as improving reading interventions and reducing inequities in student support systems.

Marta Biagioliمشاهده پروفایل

پژوهشگر

• Neurodegenerative Diseases
• Genetics
• RNA Biology
• +۲ مورد دیگر

Marta Biagioli is a Researcher in Genetics at the Department of Cellular, Computational and Integrative Biology (CIBIO) , University of Trento. Her work focuses on Huntington's disease and neurodevelopmental disorders , combining molecular genetics , RNA biology , and translational research . Her research investigates RNA biogenesis defects in Huntington’s disease, including circular RNAs (circHTT) and SINEUP antisense RNAs . She explores how CAG repeat expansions alter splicing dynamics and neuronal vulnerability , with implications for biomarker development and RNA-based therapies . Key trends in her publications reveal expertise in non-coding RNA , neurogenetic mechanisms , and epigenetic regulation . Her work spans model systems , transcriptomic analysis , and therapeutic design for diseases like Huntington’s and autism. Marta’s laboratory at CIBIO integrates interdisciplinary approaches to decode complex disease phenotypes. She actively engages in science communication , bridging academic research with public understanding through platforms like #UniTrentoStories.

Andreas Grabruckerمشاهده پروفایل

استاد

• Neuroscience
• Trace Metal Biology
• Synaptopathies
• +۴ مورد دیگر

Andreas Grabrucker is a Professor at the University of Limerick (Ireland), holding joint appointments in the Bernal Institute, Department of Biological Sciences, Health Research Institute, and Limerick Digital Cancer Research Centre. His research focuses on trace metal biology, particularly zinc’s role in synaptic function, neurodevelopmental disorders, and gut-brain interactions. He has pioneered studies on zinc’s regulatory mechanisms in the CNS and developed novel nanotechnology-based drug delivery systems. Key areas include autism spectrum disorders (ASD), Alzheimer’s disease, and the interplay of genetic and environmental factors in neurological conditions. Education: Diploma in Biology (TU Munich, Germany, 2005) PhD in Molecular Medicine (University Ulm, Germany, 2009) Research Interests: His work investigates how zinc dysregulation contributes to synaptic dysfunction in ASD and neurodegenerative diseases. He explores nanocarrier technologies to deliver therapeutic agents across the blood-brain barrier and uses 3D organoid models derived from human induced pluripotent stem cells (hIPSCs) to study disease mechanisms. Recent studies emphasize zinc’s role in gut microbiota composition, inflammatory bowel disease, and depression. Awards: Teaching Hero Award (2021) Collaborations & Leadership: He served as Executive Director of the Neurocenter at Ulm University (2011–2016) and currently leads a research cluster at the Bernal Institute. He is a Guest Associate Professor at the University of Modena and Reggio Emilia (Italy) and actively contributes to initiatives addressing UN Sustainable Development Goals related to health and innovation. Labs & Teams: His lab focuses on metallomics, nanomedicine, and translational research in neurodevelopmental disorders. Collaborations involve multidisciplinary teams studying drug delivery systems, organoid models, and clinical biomarkers for ASD and Alzheimer’s.

Françoise Baylisمشاهده پروفایل

استاد پژوهشی

• Bioethics
• Genetic Technologies
• Public Policy
• +۳ مورد دیگر

Françoise Baylis is a Distinguished Research Professor at Dalhousie University’s Faculty of Medicine and a leading figure in bioethics. She is affiliated with the NTE Impact Ethics research group, where she focuses on ethical issues in science and biotechnology, particularly heritable human genome editing, the body economy, and assisted reproduction. Her work bridges policy, practice, and public engagement, emphasizing social justice and the common good. Baylis holds prestigious awards, including membership in the Order of Canada and the Order of Nova Scotia, and is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences. She has been recognized with the Canadian Bioethics Society Lifetime Achievement Award (2017). Her research explores the ethical implications of genetic technologies, reproductive rights, and global health governance. She advocates for broad societal consensus in decision-making around genome editing and challenges the commodification of the human body. Baylis frequently contributes to public discourse through media appearances, policy consultations, and international conferences. Key themes in her work include ethical governance of emerging technologies, equity in healthcare access, and the intersection of science with social justice. She has authored influential books and articles, including Altered Inheritance: CRISPR and the Ethics of Human Genome Editing (2019), and has advised on national and global policies.

Joseph Linمشاهده پروفایل

استاد

• Molecular Biology
• Immunology
• Signal Transduction
• +۳ مورد دیگر

Joseph Lin is a Professor in the Department of Biology at Sonoma State University, affiliated with the College of Science, Technology, and Business. He holds a Ph.D. from the University of California, San Francisco (2003), and completed postdoctoral research at Washington University in Saint Louis. His research focuses on T cell activation mechanisms and redox biology, particularly the signaling pathways governing immune responses and autoimmune disease prevention. He teaches courses in molecular biology, immunology, and virology. Research interests include molecular and cellular biology, signal transduction, immunology, and the chemical biology of hydropersulfides. His work explores how T cells balance pathogen response and self-tolerance, with a focus on intracellular signaling pathways and redox regulation. Recent studies investigate hydropersulfides' roles in cellular protection, antioxidant defense, and redox signaling. Selected publications span topics like hydrogen sulfide biochemistry, hydropersulfide reactivity, and oxidative stress responses. His lab's findings contribute to understanding redox biology's role in health and disease. Teaching responsibilities include advanced courses such as Immunology (BIOL 480) and Molecular Virology (BIOL 383).

• Phytoremediation
• Environmental Toxicology
• Plant-Microbe Interactions
• +۵ مورد دیگر

Lee Newman is an Associate Professor and Chair of Chemistry at the State University of New York College of Environmental Science and Forestry (SUNY ESF). He holds a PhD in Microbiology and Molecular Genetics from Rutgers University and Robert Wood Johnson Medical School (1993). His research focuses on environmental remediation, plant-microbe interactions, and sustainable energy solutions. Key areas include phytoremediation, endophytic bacteria enhancement, nanoparticle interactions, and hyperspectral imaging for contaminant detection. Education: PhD, Microbiology and Molecular Genetics, Rutgers University & Robert Wood Johnson Medical School, 1993 Research Interests: Newman's work spans phytoremediation of heavy metals and PFAS, biomass energy production, environmental toxicity assessment, and the application of endophytic bacteria to improve plant resilience and productivity. He explores novel biotechnologies such as green walls for wastewater treatment and hyperspectral imaging for contaminant tracking. Student Supervision: Current advisees include Daniel Collins (Therapeutic Horticulture), Morgan Fatowe (PFAS Bioremediation), and others focusing on phytoremediation and environmental chemistry. Research Trends: Recent publications highlight advancements in PFAS phytoremediation, therapeutic horticulture impacts, and green wall systems for industrial waste treatment. His work bridges environmental science with engineering solutions for sustainable ecosystems. Grants & Labs: While specific grants are not listed, his research likely involves collaborative projects in environmental biotechnology and nanotechnology. He leads initiatives in SUNY ESF's Department of Chemistry, emphasizing practical applications of plant-based solutions.

• Cell metabolism
• Health and community services
• Medical physiology
• +۷ مورد دیگر

Deborah Sloboda is a Professor in the Department of Biochemistry and Biomedical Sciences at McMaster University , with associate memberships in Obstetrics, Gynecology, and Pediatrics. She maintains an Honorary Research Fellow position at the Liggins Institute in New Zealand and leads the Sloboda Lab , focusing on developmental programming and maternal-fetal health. Tier 2 Canada Research Chair in Perinatal Programming (2012–2022) Founding Co-President, DOHaD Society of Canada Former Secretary, International Society for Developmental Origins of Health and Disease Research Interests span developmental programming, maternal nutrition, placental function, and long-term health outcomes. Her work integrates evolutionary anthropology, epigenetics, and microbiome studies to understand how early-life nutritional adversity affects metabolic and reproductive systems. Scientific Awards International Society of DOHaD Nick Hales Award (2015) Hamilton YWCA Woman of Distinction Award in Science, Trade, and Technology (2017) Publications (>130) emphasize sex-specific effects of maternal diets, glucocorticoid exposure , and microbiome-immune interactions in pregnancy. Recent work explores syndemic effects of food insecurity and epigenetic impacts of paternal obesity.

Wendy Russellمشاهده پروفایل

پژوهشگر ارشد

• Social Dimensions of Energy Technologies
• Responsible Innovation
• Transdisciplinarity
• +۴ مورد دیگر

Wendy Russell is a Research Fellow at the ANU Centre for Energy Systems within the ANU College of Systems & Society. She previously held roles in the Battery Storage & Grid Integration Program (School of Engineering, ANU) and the Centre for the Public Awareness of Science. With a PhD in Botany from The University of Queensland, her career spans biological sciences academia, public policy, and consulting. Russell specializes in the social dimensions of energy transitions, responsible innovation, and transdisciplinary research. Her work bridges science communication, public engagement, and policy impact. Educations: PhD in Botany, The University of Queensland (1997) B.Sc. (Hons 1st Class) in Botany, The University of Queensland (1991) B.Sc. in Biochemistry, The University of Queensland (1989) Research Interests: Russell investigates how societies navigate energy transitions through public engagement and responsible innovation frameworks. She explores transdisciplinary approaches to integrate diverse knowledge systems and improve research impact. Her work emphasizes ethical technology assessment and fostering dialogue between stakeholders in energy policy and biotechnology sectors. Key themes include democratizing energy decision-making, care practices in energy systems, and fostering innovation governance. Key Article Trends: Recent publications focus on reimagining responsible innovation frameworks, decentralized energy systems governance, and transdisciplinary pedagogy. Earlier work addressed nanotechnology policy, agricultural biotechnology regulation, and educational program efficacy. Awards: 2013 IAP2 Core Values Award (ACT Region) 2011 IAP2 National Project of the Year 2006 Carrick Institute Citation for Outstanding Teaching Advising & Grants: Russell has coordinated national conferences on neighborhood batteries and led projects under Commonwealth departments. She currently chairs the EvoEnergy Energy Regulatory Advisory Panel and curates the Social Science Community of Practice at ANU. Her affiliations include the University of Canberra’s Centre for Deliberative Democracy and Global Governance. Labs & Teams: Active in ANU’s STS Network, Knowledge-to-Action Network, and the BSGIP Social Science Community of Practice.

Zeribe Nwosuمشاهده پروفایل

استادیار

• Cancer Metabolism
• Pancreatic Cancer
• Therapeutic Targeting
• +۷ مورد دیگر

Zeribe Nwosu is an NIH Cornell Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Assistant Professor in the Department of Molecular Biology and Genetics at Cornell University. His research focuses on cancer metabolism, particularly pancreatic cancer, with emphasis on nutrient utilization, tumor microenvironment interactions, and therapeutic strategies to disrupt metabolic pathways. He holds a PhD in Molecular and Cellular Biology from the University of Heidelberg, Germany, and completed postdoctoral training at the University of Michigan, where he studied pancreatic cancer metabolism. Education: Bachelor of Medical Laboratory Science, Ebonyi State University, Nigeria (2007) MSc in Biomedical Science, London Metropolitan University, UK (2012) PhD in Molecular and Cellular Biology, University of Heidelberg, Germany (2017) Postdoctoral Research Fellow, University of Michigan, USA (2023) Research Interests: Identification of nutrient transporters and metabolic regulators in cancer cells Role of glutathione (GSH) in pancreatic cancer survival and drug resistance Impact of metabolic diseases (e.g., diabetes) on cancer progression Development of novel drug combinations targeting metabolic vulnerabilities Integration of functional genomics and drug screening for therapeutic discovery Awards & Funding: NIH K99/R00 Pathway to Independence Award (2023) AACR Scholar-in-Training Award (2023) Funded by NIH/NCI, Cornell University, and the FIRST program Labs & Teams: The Nwosu Lab utilizes cutting-edge technologies including metabolomics, CRISPR/Cas9, Seahorse analysis, and mouse models to study cancer metabolism. Key collaborations involve bioinformatics and clinical translation.

Bradley Bernsteinمشاهده پروفایل

استاد

• Epigenetics
• Cancer Biology
• Chromatin Regulation
• +۳ مورد دیگر

Bradley Bernstein, M.D., Ph.D., is a Professor of Pathology and Cell Biology at Harvard Medical School and Chair of Cancer Biology at Dana-Farber Cancer Institute. He holds the Richard and Nancy Lubin Family Chair and directs the Broad Institute’s Gene Regulation Observatory and Epigenomics Program. His research focuses on epigenetic mechanisms in development and cancer, including chromatin regulation, bivalent domains, and cancer epigenetics. He has pioneered technologies like ENCODE and advanced understanding of noncoding DNA’s role in gene regulation. His work spans cancer mechanisms, stem cell circuits, and therapeutic resistance. Notable contributions include identifying bivalent chromatin states and linking epigenetic changes to oncogene activation in gliomas. Education: B.S. from Yale University (1992), M.D. and Ph.D. from University of Washington (1999), postdoctoral training at Harvard University. Affiliations include Dana-Farber Cancer Institute, Broad Institute, and Ludwig Institute. Research Interests: Epigenetic gene regulation, chromatin structure, cancer epigenetics, developmental hierarchies, single-cell technologies, and translational applications in oncology. Key areas include bivalent domains, tumor self-renewal, and epigenetic therapies. Awards: Richard and Nancy Lubin Family Chair, Ludwig Institute Investigator. Advising & Grants: Mentor to numerous graduate students and postdocs. Leads large-scale consortia (e.g., ENCODE, BLUEPRINT). Active in technology development for epigenomic mapping. Labs/Teams: Bernstein Lab at Dana-Farber and Broad Institute, Epigenomics Program, and Gene Regulation Observatory. Collaborates widely across academia and industry.

Joanne Lordمشاهده پروفایل

استاد

• Health Economics
• Health Technology Assessment
• Cost-Effectiveness Analysis
• +۴ مورد دیگر

Professor Joanne Lord is a health economist specializing in cost-effectiveness analysis and decision modelling at the University of Southampton. She directs the Southampton Health Technology Assessments Centre (SHTAC), which provides clinical and economic evidence for NICE guidelines. Her research focuses on health technology assessment, with projects including newborn screening reviews, tuberculosis evaluations, and cardiovascular disease analyses. She leads NIHR-funded Technology Assessment Review (TAR) reports and collaborates on EU Horizon2020 projects like the FAIR trial for drug-resistant bacterial pneumonia. Education & Career: Joanne holds degrees in economics, mathematics, and health economics. She has worked at the Department of Health, St George's Hospital Medical School, Imperial College, and Brunel University before joining the University of Southampton in 2015. She contributed to NICE’s early technology appraisals and clinical guidelines teams, aligning with her current work at SHTAC. Research Projects: Active projects include SHTAC’s NIHR TAR reports, the FAIR trial, and collaborations on trials such as CONFIRM (mesothelioma therapy), OCTOPuS (cardiac surgery outcomes), and EACH-B (adolescent health interventions). She also oversees studies like WRAPPED, evaluating supermarket-based dietary strategies. Labs/Teams: Leads SHTAC and collaborates with multidisciplinary teams across universities on projects involving health economics and clinical research. Her work integrates economic evaluations with clinical trials to inform healthcare policy and practice.

Jim Roweمشاهده پروفایل

پژوهشگر ارشد

• Plant Stress Responses
• Plant Hormone Biology
• Abscisic Acid (ABA) Dynamics
• +۵ مورد دیگر

Dr Jim Rowe is a Royal Society University Research Fellow at the University of Sheffield's School of Biosciences. His work focuses on plant stress responses, particularly drought tolerance mechanisms mediated by abscisic acid (ABA). He developed the ABACUS2 biosensor to visualize ABA dynamics in living plants, revealing context-dependent hormone patterns critical for water conservation. Rowe's research integrates synthetic biology, imaging tools, and systems biology to engineer stress-resilient crops. PhD: Durham University (2011-2015) Postdoctoral research: Stuart Casson Lab (2016-2017), Alexander Jones Lab (2017-2024) Research interests include ABA signaling pathways, plant water relations, and crop resilience to 'flash droughts'. His group uses novel technologies like FRET-based biosensors and image analysis tools (FRETENATOR) to study hormone dynamics. Current projects aim to link ABA patterns to functional outcomes in root and leaf physiology. Grants: £1.52m Royal Society Fellowship (2024-2032) Key awards: Royal Society University Research Fellowship Publications span plant physiology, biosensor development, and systems biology, with notable contributions to understanding ABA's role in drought resistance and hormone crosstalk. Lab activities include 3D-printed hardware design for experimental setups and collaborations on microcontroller-based instrumentation.

• Immunology
• Proteomics
• Mass Spectrometry
• +۳ مورد دیگر

Prof. Felix Meissner is a Professor and Head of the Department of Systems Immunology & Proteomics at the Institute of Innate Immunity, University Hospital Bonn. His research focuses on understanding immune signaling circuits using mass spectrometry-based proteomics, systems biology, and biochemical approaches. He investigates how self/non-self signals are sensed and transmitted in immune systems to regulate inflammation and immunity. Education & Career: Biochemistry studies at Free University of Berlin and Scripps Research Institute Doctorate at Max Planck Institute for Infection Biology Postdoctoral work at Max Planck Institute of Biochemistry and UCSF Independent Group Leader at MPI of Biochemistry (Munich) Since 2021: Professor at University of Bonn Research Interests: Proteomics-driven discovery of immune signaling pathways Systems-level analysis of inflammation regulation Development of novel proteomic tools (e.g., EASI-tag) Translational applications in drug discovery and therapeutics Labs & Collaborations: Joint lab at University of Bonn and Max Planck Institute of Biochemistry Co-founder of Odyssey Therapeutics (translating proteomic discoveries) Key projects: Target deconvolution, intercellular communication analysis